Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Iowa for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Iowa only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Iowa (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Rasa Buntinas (NPI 1902880966)

Field	Value
Entity Type	Individual
Organization	Rasa Buntinas
Address	202 10th Street Se
City	Cedar Rapids
State	IA
ZIP	52403
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	December 2, 2005

Payer Source	Total Paid
Medicare	$1.1M
Medicaid	$0

Key Findings

Top-line concentration: this provider’s Medicare revenue is $1.1M and is highly concentrated — the precomputed top 3 Medicare codes account for 62.8% of that total. The three highest-revenue codes are J1569 ($286.2K, 26.7%), J0897 ($249.5K, 23.2%), and 78815 ($138.9K, 12.9%), indicating a small number of services drive the majority of Medicare dollars. This concentration suggests targeted service lines rather than a broad, evenly distributed billing mix.

Business/service-line implications: taxonomy as a Hematology & Oncology Physician combined with dominant codes J1569 and J0897 points to a clinic that delivers infusion biologics and bone-modifying agents as a primary revenue stream. The presence of 78815 (PET/CT) as a top revenue source alongside chemotherapy administration codes (e.g., 96413, 96365) reinforces an oncology practice pattern that couples inpatient/outpatient imaging for staging with onsite drug administration and supportive care. Together, the mix is consistent with an outpatient oncology infusion practice that coordinates diagnostic imaging and systemic therapy.

Payer mix and single-payer reliance: this provider effectively operates on a Medicare-only book of business for public payers — total Medicare revenue is $1.1M and there is no Medicaid billing on file. That lack of Medicaid activity means analyses of Medicaid exposure, state Medicaid risk, or dual-eligible mixes are not applicable, and contracting or network strategies will be driven almost entirely by Medicare dynamics.

Competitive standing on leading drugs and imaging: relative ranks show mixed competitive intensity. J0897 ranks #622 of 10057 providers nationally (94th percentile; typical, unremarkable volume for this code) and J1569 ranks #79 of 542 providers nationally (86th percentile; typical, unremarkable volume for this code), indicating above-average national presence for these biologic injections but not dominance. By contrast, 78815 ranks #1595 of 6566 (75th percentile; typical, unremarkable volume for this code), so imaging volume is solid but not exceptional compared with national peers.

Statistical outliers in E/M and selected drugs: certain items are flagged as extreme outliers, notably 99214 (rank #4837 of 479517, 99th percentile; extreme outlier, far above typical national volume for this code) and J3489 (rank #38 of 3032, 99th percentile; extreme outlier, far above typical national volume for this code). High relative ranks for 99214 and J3489 indicate unusually heavy established-patient office visit activity and very high zoledronic acid billing compared with most providers, which may reflect practice focus on ongoing medical management and bone-targeted therapy.

Utilization profile nuance: some codes show very high claim counts but low per-claim payment, for example J1439 appears as 54K claims at $1 avg paid/claim yielding $54K revenue. This pattern — high utilization paired with low average payment — suggests those line items drive operational throughput without contributing large per-claim revenue, and should be interpreted differently from the high-dollar biologic codes that dominate revenue.

Supportive care and infusion ecosystem: the code mix includes supportive oncology services such as J2506 (pegfilgrastim, 552 claims, $44.7K revenue), J0185 (aprepitant, 9.8K claims, $9.8K revenue), and multiple infusion administration codes (96413, 96365, 96375). These entries reinforce that the practice provides both antineoplastic therapy and the supportive medications/services that accompany systemic cancer treatment, consistent with a comprehensive outpatient oncology infusion model.

Tenure and likely referral stability: the NPI was enumerated on 2005-12-02 (~21 years ago), indicating long tenure in the Medicare program. That longevity suggests an established referral footprint and billing continuity, which may explain persistent high-volume lines (e.g., 99214, J3489) rather than transient spikes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

64 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	7,950	$40	$286.2K
J0897	Injection, denosumab, 1 mg	13,860	$20	$249.5K
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	130	$1,090	$138.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,370	$90	$124.4K
J1439	Injection, ferric carboxymaltose, 1 mg	54,000	$1	$54K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	550	$80	$44.7K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	290	$100	$27.3K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	120	$150	$17.8K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	110	$130	$14.8K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	1,470	$10	$14.7K

Showing 1–10 of 64

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 64 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Iowa Distribution

Rasa Buntinas — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Iowa

Full comparison — all codes billed, vs. state median

64 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J1569	2	10	2,680	$40	$133.6K
J0897	10	190	1,920	$20	$74.1K
J1439	2	10	41,250	$1	$39.7K
J2506	5	20	440	$80	$38.9K
96413	28	80	210	$90	$24K
78815	15	90	40	$270	$20.4K
91322	415	580	80	$140	$15.2K
J0185	4	20	6,890	$1	$14.5K
99214	14	4,690	100	$70	$14.4K
74177	194	210	130	$80	$12.5K

Showing 1–10 of 64

Related Providers

Other providers that share a Tax Identification Number (TIN) with Rasa Buntinas, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Physicians' Clinic Of Iowa, PC	IA	Surgery Physician	$0	$4.9M
Bogdan Cherascu	IA	Rheumatology Physician	$2.4M	$0
Vijay Aluri	IA	Rheumatology Physician	$2M	$0
Bharat Jenigiri	IA	Medical Oncology Physician	$1.5M	$0
William Fusselman	IA	Hematology & Oncology Physician	$1.3M	$0
Ritu Munjal	IA	Family Medicine Physician	$1M	$0
Harinder Singh	IA	Rheumatology Physician	$789.3K	$0
Jonathan Rippentrop	IA	Urology Physician	$487.4K	$0
Thomas Richardson	IA	Urology Physician	$373K	$0
Sandeep Munjal	IA	Adult Reconstructive Orthopaedic Surgery Physician	$322K	$0

Nearby Providers

Other providers in the same ZIP code as Rasa Buntinas, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mercy Medical Center	IA	General Acute Care Hospital	$0	$26.4M
Eastern Iowa Health Center	IA	Family Medicine Physician	$0	$24.5M
Eastern Iowa Health Center	IA	Family Medicine Physician	$0	$18.5M
Eastern Iowa Health Center	IA	General Practice Dentistry	$0	$14.4M
Linn County Emergency Medicine PC	IA	Emergency Medicine Physician	$0	$9.8M
C R Iv Service Inc	IA	Home Infusion Therapy Pharmacy	$0	$5.8M
Mercy Medical Center	IA	Cardiovascular Disease Physician	$0	$5.1M
C R Pharmacy Service Inc	IA	Oxygen Equipment & Supplies (DME)	$0	$2.4M
Eastern Iowa Sleep Center, LLC	IA	Sleep Disorder Diagnostic Clinic/Center	$243.7K	$1.6M
Rapids Dental	IA	Dental Clinic/Center	$0	$1.7M

Rasa Buntinas — Billing Profile & Reimbursement Data

Sign up for Rasa Buntinas — Billing Profile & Reimbursement Data policy alerts

Rasa Buntinas — Billing Profile & Reimbursement Data

Sign up for Rasa Buntinas — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References